DMN Valuation
Damon Inc
$
0.007
- Overview
- Forecast
- Valuation
DMN Relative Valuation
DMN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DMN is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-0.02
P/B
Median3y
-3.37
Median5y
-3.37
-386.70
FCF Yield
Median3y
-231.99
Median5y
-231.99
Competitors Valuation Multiple
The average P/S ratio for DMN's competitors is 0.18, providing a benchmark for relative valuation. Damon Inc Corp (DMN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch
CENT
Central Garden & Pet Co
33.910
USD
+1.04%
MUX
McEwen Mining Inc
7.520
USD
-3.59%
MREO
Mereo BioPharma Group PLC
2.600
USD
+0.39%
SMC
Summit Midstream Corp
27.250
USD
-2.12%
PACB
Pacific Biosciences of California Inc
1.110
USD
0.00%
CVGW
Calavo Growers Inc
27.020
USD
-2.17%
AAM
AA Mission Acquisition Corp
10.320
USD
+0.10%
TCBX
Third Coast Bancshares Inc
30.310
USD
+1.71%
URGN
Urogen Pharma Ltd
11.410
USD
-1.98%
GCO
Genesco Inc
19.480
USD
+0.41%
FAQ
Is Damon Inc (DMN) currently overvalued or undervalued?
Damon Inc (DMN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Damon Inc (DMN) is between to according to relative valuation methord.
What is Damon Inc (DMN) fair value?
How does DMN's valuation metrics compare to the industry average?
What is the current P/B ratio for Damon Inc (DMN) as of May 02 2025?
What is the current FCF Yield for Damon Inc (DMN) as of May 02 2025?
What is the current Forward P/E ratio for Damon Inc (DMN) as of May 02 2025?